The Board granted service connection for multiple myeloma, monoclonal gammopathy of unknown significance (MGUS), and smoldering myeloma on a presumptive basis due to herbicide exposure during the Veteran's service in Korea.
The deciding factor: The evidence shows the Veteran was exposed to herbicides during his service near the DMZ in Korea, and MGUS is a condition associated with such exposure under 38 U.S.C. § 1116B.
- Claimed conditions
- multiple myeloma, monoclonal gammopathy of unknown significance (MGUS), smoldering myeloma
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- Camp Lejeune water
- Rating assigned
- 100%
- Decision date
- October 31, 2024
- Citation
- A24070834
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Board denied service connection for multiple myeloma, finding no evidence that the Veteran's condition was related to his military service.
- Dismissed
The veteran withdrew all claims on appeal, and the Board dismissed the appeal.
- Granted
The Board granted service connection for multiple myeloma, finding that the Veteran's condition was caused by his conceded in-service toxic risk exposure activities.
- Remanded (sent back)
The Board remands the Veteran's claim for service connection for multiple myeloma due to a pre-decisional duty to assist error in not providing the Veteran with a VA examination and medical opinion.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.